Margherita Iaboni

Title: Margherita Iaboni: Innovator in Nucleic Acid Aptamers

Introduction

Margherita Iaboni is a notable inventor based in Qualiano, Italy. She has made significant contributions to the field of nucleic acid aptamers, focusing on their diagnostic and therapeutic applications. With a total of 2 patents, her work is paving the way for advancements in medical diagnostics and treatments.

Latest Patents

Iaboni's latest patents include "CA-IX aptamers and diagnostic and therapeutic uses thereof." This invention provides nucleic acid aptamers that bind to the Carbonic Anhydrase IX (CA-IX) enzyme, along with derivatives and conjugates. These aptamers serve as diagnostic tools, particularly for imaging organs and tissues that express CA-IX, and as therapeutic agents for the prevention or treatment of CA-IX related diseases. Another significant patent is "ICAM-1 aptamers, diagnostic and therapeutic uses thereof." This invention offers nucleic acid aptamers that bind to the Intercellular Adhesion Molecule-1 (ICAM-1), along with their derivatives and conjugates. Similar to her CA-IX patent, these aptamers are utilized as diagnostic tools for imaging and as therapeutic agents for ICAM-1 related diseases.

Career Highlights

Margherita Iaboni is currently associated with Bracco Imaging S.p.A., a company known for its innovative imaging solutions. Her work at Bracco Imaging has allowed her to focus on the development of advanced diagnostic tools that can significantly impact patient care.

Collaborations

Iaboni collaborates with esteemed colleagues such as Vittorio De Franciscis and Silvia Catuogno. These collaborations enhance her research and contribute to the development of groundbreaking technologies in the field of medical diagnostics.

Conclusion

Margherita Iaboni's contributions to the field of nucleic acid aptamers are noteworthy and have the potential to revolutionize diagnostic and therapeutic practices. Her innovative work continues to inspire advancements in medical science.